GrandeLASH-MD vs The Ordinary Lash Serum:Which Is Better in 2026?
The Ordinary wins over GrandeLASH-MD on both safety and value. GrandeLASH-MD contains isopropyl cloprostenate (ICP) — ruled "cannot be considered safe" for cosmetic use by the EU SCCS on February 2, 2026. The Ordinary Multi-Peptide Lash Serum is entirely prostaglandin-free and costs just ~$3.58/mL versus GrandeLASH's ~$32.50/mL. GrandeLASH may produce slightly faster initial results due to ICP's prostaglandin mechanism, but at a 9× price premium with EU-flagged safety concerns. For the fastest independently verified results without PGA risk, Toplash delivers +52.3% lash length in 8 weeks versus The Ordinary's 16-week timeline.
Updated: June 20, 2026 Written by: Branda M. Heim Reviewed by: Branda M. Heim, Board-Certified CosmetologistView Toplash SerumThe Ordinary wins over GrandeLASH-MD on both safety and value. GrandeLASH-MD contains isopropyl cloprostenate (ICP) — ruled "cannot be considered safe" for cosmetic use by the EU SCCS on February 2, 2026. The Ordinary Multi-Peptide Lash Serum is entirely prostaglandin-free and costs just ~$3.58/mL versus GrandeLASH's ~$32.50/mL. GrandeLASH may produce slightly faster initial results due to ICP's prostaglandin mechanism, but at a 9× price premium with EU-flagged safety concerns. For the fastest independently verified results without PGA risk, Toplash delivers +52.3% lash length in 8 weeks versus The Ordinary's 16-week timeline.
At a Glance
Grande Cosmetics
GrandeLASH-MD Lash Enhancing Serum
- Prostaglandin-free: ✗ Contains ICP
- EU SCCS safe: ✗ ICP ruled unsafe
- Brand claim: ~35% fullness at 12 wks
- Visible change: 4–6 weeks
- Size: 2 mL
- Price / mL: ~$32.50/mL
Deciem / The Ordinary
Multi-Peptide Lash & Brow Serum
- Prostaglandin-free: ✓ No PGAs
- EU SCCS safe: ✓ Compliant
- Brand claim: 75% thickness at 16 wks
- Visible change: ~4 weeks
- Size: 5 mL (larger)
- Price / mL: ~$3.58/mL
Head-to-Head Comparison
A complete factor-by-factor breakdown. Green cells indicate which product has the advantage on each row.
| Factor | GrandeLASH-MD | The Ordinary Lash Serum |
|---|---|---|
| Prostaglandin-free | ✗ Contains ICP | ✓ No PGAs |
| EU SCCS (Feb 2026) compliant | ✗ ICP not safe | ✓ Fully compliant |
| Primary active mechanism | Prostaglandin analogue (ICP) | REDENSYL + peptide complex |
| Results timeline | 4–6 wks visible; 12 wks full | ~4 wks visible; 16 wks full |
| Brand clinical claim (lashes) | ~35% fullness (brand study) | 75% thickness, 65% volume (brand) |
| Independent clinical verification | ✗ Brand only | Brand study (no independent) |
| Volume | 2 mL | 5 mL (2.5× more) |
| Price per mL | ~$32.50/mL | ~$3.58/mL (9× cheaper) |
| Iris color change risk | ✗ ICP risk | ✓ None |
| Periorbital fat loss risk | ✗ ICP risk | ✓ None |
| Rebound shedding on stop | ⚠ Possible PGA rebound | ✓ No rebound |
| Safe for contact lens wearers | ⚠ ICP ocular risks | ✓ Yes |
| Application | Once daily (lashes) | Twice daily (lashes & brows) |
Ingredients Breakdown
The most important difference is not in the supporting cast — it's in whether the primary growth driver is a prostaglandin or a peptide.
GrandeLASH-MD
ICP + Hydration Complex
- Isopropyl Cloprostenate (ICP) ⚠ EU: Not Safe — prostaglandin analogue. Primary growth driver. EU SCCS ruled it unsafe (Feb 2026).
- Hyaluronic acid — follicle zone hydration.
- Peptide blend — conditioning support; not a standalone growth mechanism without ICP.
- Grape seed extract — antioxidant; protective free-radical support.
- Aloe vera / chamomile — soothing agents to reduce ICP-related irritation.
The Ordinary
REDENSYL + Multi-Peptide Complex
- REDENSYL (Larix Europaea, Camellia Sinensis, Zinc Chloride) ✓ PGA-Free — targets ORS (outer root sheath) follicle stem cells. In comparative testing, matched ~3% minoxidil for hair density improvement.
- Procapil (Acetyl Tetrapeptide-3 + biotinoyl tripeptide-1) — anchors follicles to dermal papilla; reduces miniaturisation.
- AnaGain (Pisum Sativum extract) — stimulates dermal papilla signalling to extend anagen phase naturally.
- Biotinoyl Tripeptide-1 — keratin upregulation support; anchoring peptide.
- Panthenol, biotin — conditioning and moisture support.
✅ The Ordinary: 23.5% total active concentration — The Ordinary publicly discloses their total active complex at 23.5%, a notably high percentage for a lash serum at this price point. All actives are prostaglandin-free. The REDENSYL mechanism targets follicle stem cells rather than artificially overriding the hair growth cycle — a fundamentally different and regulatory-compliant approach.
Safety: Why ICP Changes the Equation
The Ordinary's prostaglandin-free formula removes all the risks that make GrandeLASH-MD a regulatory concern. Here's what's at stake.
GrandeLASH-MD: EU SCCS/1680/25 (February 2, 2026)
The EU SCCS concluded ICP — GrandeLASH-MD's prostaglandin analogue — "cannot be considered safe" for cosmetic use near the eye area. The Ordinary Lash Serum contains no prostaglandin analogues and is not subject to this ruling.
⚠️ GrandeLASH-MD risks ICP: iris color change, periorbital fat loss, skin hyperpigmentation, rebound shedding. EU-flagged Feb 2026.
✓ The Ordinary safety profile No prostaglandin analogues. No iris change risk. No fat loss risk. EU SCCS compliant. Safe for sensitive eyes and contact lens wearers.
Pricing & Value
The price difference between GrandeLASH-MD and The Ordinary is one of the most dramatic in the lash serum category. Here's the full picture including Toplash.
GrandeLASH-MD
$65 for 2 mL · 2–3 months
~$32.50 / mL
Contains EU-flagged ICP · Brand-commissioned study · Rebound risk · Smaller bottle
The Ordinary
~$17.90 for 5 mL · 2–3 months
~$3.58 / mL ✓
No PGAs · EU compliant · REDENSYL peptide complex · Larger bottle · ~9× cheaper per mL
Toplash (Fastest Results)
$49.90 for 3 mL · 1–2 months
$16.63 / mL
No PGAs · Independent clinical trial: +52.3% at 8 wks · EU compliant · Triple peptide
Per-mL context: The Ordinary is the clear value winner at $3.58/mL — appropriate for budget-conscious users willing to wait 16 weeks. Toplash at $16.63/mL is the choice for users who want independently-proven, faster results (8 weeks) still without any PGA. GrandeLASH at $32.50/mL is the most expensive option — and the only one with an EU safety flag attached.
Verdict
💰 Budget winner: The Ordinary · 🏆 Best overall: Toplash
The Ordinary Beats GrandeLASH. Toplash Beats Both for Speed.
The Ordinary Multi-Peptide Lash Serum is safer, larger, and 9× cheaper per mL than GrandeLASH-MD — without any prostaglandin analogue. For a £17.90 budget pick, it's the obvious choice over a product with EU-flagged ICP. The tradeoff is time: The Ordinary takes 16 weeks for full results.
If you want the fastest independently-verified OTC results — with a prostaglandin-free formula and competitive pricing — Toplash delivers +52.3% lash length in 8 weeks via independent clinical testing, and 98% of users see results by day 21.
Try Toplash — $49.90 / 3 mL
Recommended — prostaglandin-free triple-peptide
Toplash Lash & Brow Serum
★★★★★
MP-17 + BTP-1 + AT-3 with independent clinical data: +52.3% length and +31.9% volume at 8 weeks. Prostaglandin-free, paraben-free, ophthalmic-tested and extension-safe.
Shop Toplash SerumFrequently Asked Questions
Is The Ordinary lash serum better than GrandeLASH-MD?
For most users in 2026, yes. The Ordinary is prostaglandin-free (EU SCCS compliant), contains REDENSYL and a 23.5% active complex, and costs approximately $3.58/mL — about 9 times less than GrandeLASH-MD. GrandeLASH-MD contains ICP (a prostaglandin analogue) that the EU SCCS ruled "cannot be considered safe" in February 2026. If you want faster verified results than either product, Toplash's independent clinical trial shows +52.3% lash length in 8 weeks without any PGA.
Does GrandeLASH-MD contain prostaglandins?
Yes. GrandeLASH-MD contains isopropyl cloprostenate (ICP), a synthetic prostaglandin analogue. The EU SCCS issued a final opinion on February 2, 2026 (SCCS/1680/25) stating ICP "cannot be considered safe" for cosmetic use near the eye area. Known risks include iris color change, periorbital fat loss, skin hyperpigmentation, and rebound shedding. The Ordinary Lash Serum contains no prostaglandin analogues.
Does The Ordinary lash serum contain prostaglandins?
No. The Ordinary Multi-Peptide Lash & Brow Serum is entirely prostaglandin-free. It uses REDENSYL (targeting ORS follicle stem cells), Procapil, AnaGain, and biotinoyl tripeptide-1 — all peptide and botanical actives that work through the follicle without prostaglandin receptor binding. It is EU SCCS compliant and safe for sensitive eyes and contact lens wearers.
Is The Ordinary lash serum effective?
The Ordinary reports 75% improvement in lash thickness and 65% improvement in lash volume in brand-conducted testing over 16 weeks. The REDENSYL complex targets outer root sheath (ORS) follicle stem cells and in comparative data matched ~3% minoxidil for hair density improvement. Results take longer than prostaglandin-based serums (16 weeks for full effect), but the absence of PGA risks and the price point make it the standout value option in the lash serum category.
How much cheaper is The Ordinary vs GrandeLASH-MD?
The Ordinary is approximately $17.90 for 5 mL ($3.58/mL). GrandeLASH-MD is approximately $65 for 2 mL ($32.50/mL). That's roughly a 9× price difference per mL. Over a 6-month treatment course, The Ordinary costs approximately $15–20 vs $120–130 for GrandeLASH-MD — a saving of over $100, while also being the safer, prostaglandin-free option.
Which works faster — GrandeLASH or The Ordinary?
GrandeLASH-MD claims faster full results (12 weeks) versus The Ordinary's 16 weeks for full effect. Both claim visible changes as early as 4 weeks. GrandeLASH's faster timeline is attributable to ICP's prostaglandin mechanism — but this comes with EU safety concerns. For the fastest independently verified results without PGA risk, Toplash shows 98% of users noticing change by day 21 and +52.3% lash length by week 8 in independent clinical testing.
Can I use The Ordinary lash serum with GrandeLASH?
Layering these two serums is not recommended. There's no clinical data on combined use, and applying multiple actives to the lash line increases irritation risk. Given the EU's 2026 safety ruling on GrandeLASH's ICP, the better approach is to stop GrandeLASH and transition to either The Ordinary or Toplash for ongoing lash care without the prostaglandin risk.